CoDa Therapeutics Closes B Round with $40 Million from Rusnano/ Domain-Led Syndicate
This article was originally published in The Pink Sheet Daily
Executive Summary
Wound healing company CoDa Therapeutics is the first Domain portfolio company to benefit from the venture capital firm’s new, $760 million partnership with Russian sovereign fund Rusnano